RxDoctor Payments Data

Louis Fehrenbacher

Hematology & Oncology · Vallejo, CANPI 1942388764

Payments from drug & device makers

$494,143in general payments, 2019–2025

Across 49 payments — averaging $10,085 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$421K
  • Medivation LLC.$27K
  • Novartis$24K
  • Pfizer$9K
  • Merck$7K
  • E.r. Squibb & Sons, L.L.C.$6K
$3,495in research payments, 2019–2025

Across 3 payments — averaging $1164.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$2K
  • Pfizer$1K

What the payments were for

  • Speaking & faculty fees$8,740100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.13$420,943
Medivation LLC.6$26,742
Novartis8$24,097
Pfizer4$8,740
Merck11$7,179
E.r. Squibb & Sons, L.L.C.7$6,443

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$494,143 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Vallejo

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →